Osimertinib in Indian patients with T790M-positive advanced nonsmall cell lung cancer

समान संसाधन

• Third-line therapy in the epidermal growth factor receptor mutation-positive advanced nonsmall-cell lung cancer
  द्वारा: Noronha, Vanita, और अन्य
  प्रकाशित: (2020)
• Outcome of uncommon EGFR mutation positive newly diagnosed advanced non-small cell lung cancer patients: a single center retrospective analysis
  द्वारा: Kate, Shruti, और अन्य
  प्रकाशित: (2019)
• Sequential treatment with alectinib in crizotinib-resistant non-small-cell lung cancer
  द्वारा: Majumdar, Swaratika, और अन्य
  प्रकाशित: (2018)
• Lorlatinib in anaplastic lymphoma kinase-positive non-small cell lung cancer: Indian experience
  द्वारा: Talreja, Vikas T., और अन्य
  प्रकाशित: (2020)
• ROS1 mutation non-small cell lung cancer—access to optimal treatment and outcomes
  द्वारा: Joshi, Amit, और अन्य
  प्रकाशित: (2019)